CS241144B2 - Method of new substituted 1,4-dihydropyridines production - Google Patents

Method of new substituted 1,4-dihydropyridines production Download PDF

Info

Publication number
CS241144B2
CS241144B2 CS839613A CS961383A CS241144B2 CS 241144 B2 CS241144 B2 CS 241144B2 CS 839613 A CS839613 A CS 839613A CS 961383 A CS961383 A CS 961383A CS 241144 B2 CS241144 B2 CS 241144B2
Authority
CS
Czechoslovakia
Prior art keywords
oxadiazol
formula
acid
group
dihydro
Prior art date
Application number
CS839613A
Other languages
Czech (cs)
English (en)
Other versions
CS961383A2 (en
Inventor
Karl Schoenafinger
Helmut Bohn
Melitta Just
Piero Martorana
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of CS961383A2 publication Critical patent/CS961383A2/cs
Publication of CS241144B2 publication Critical patent/CS241144B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Protection Of Plants (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS839613A 1982-12-20 1983-12-19 Method of new substituted 1,4-dihydropyridines production CS241144B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823247118 DE3247118A1 (de) 1982-12-20 1982-12-20 Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
CS961383A2 CS961383A2 (en) 1985-07-16
CS241144B2 true CS241144B2 (en) 1986-03-13

Family

ID=6181182

Family Applications (1)

Application Number Title Priority Date Filing Date
CS839613A CS241144B2 (en) 1982-12-20 1983-12-19 Method of new substituted 1,4-dihydropyridines production

Country Status (20)

Country Link
US (1) US4558058A (da)
EP (1) EP0116708B1 (da)
JP (1) JPS59118783A (da)
KR (1) KR840006969A (da)
AT (1) ATE19776T1 (da)
AU (1) AU562583B2 (da)
CA (1) CA1194480A (da)
CS (1) CS241144B2 (da)
DD (1) DD215548A5 (da)
DE (2) DE3247118A1 (da)
DK (1) DK562683A (da)
ES (1) ES528175A0 (da)
FI (1) FI834451A (da)
GR (1) GR79484B (da)
HU (1) HU194556B (da)
NO (1) NO834480L (da)
PH (1) PH20327A (da)
PL (1) PL140526B1 (da)
SU (1) SU1360585A3 (da)
ZA (1) ZA839382B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3431862A1 (de) * 1984-08-30 1986-03-13 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5326772A (en) * 1984-09-28 1994-07-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Diaryl compounds for their use
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
US4650805A (en) * 1985-12-02 1987-03-17 Warner-Lambert Company 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0296316B1 (de) * 1987-03-27 1993-09-01 Byk Gulden Lomberg Chemische Fabrik GmbH 1,4-Dihydropyridin-Enantiomere
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
US7312337B2 (en) * 2004-09-30 2007-12-25 Eastman Kodak Company Oxadiazoles and their manufacture
DE102006044696A1 (de) * 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647809A (en) * 1968-04-26 1972-03-07 Chinoin Gyogyszer Es Vegyeszet Certain pyridyl-1 2 4-oxadiazole derivatives
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
DE2005116C3 (de) * 1970-02-05 1980-02-14 Bayer Ag, 5090 Leverkusen Symmetrische 1,4-Dihydropyridin-3,5-dicarbonsäureester
CA962269A (en) * 1971-05-05 1975-02-04 Robert E. Grahame (Jr.) Thiazoles, and their use as insecticides
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
DE2747513A1 (de) * 1977-10-22 1979-05-03 Bayer Ag Dihydropyridine mit schwefelhaltigen estergruppierungen
US4144343A (en) * 1978-01-04 1979-03-13 Merck & Co., Inc. Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use

Also Published As

Publication number Publication date
AU562583B2 (en) 1987-06-11
PL140526B1 (en) 1987-05-30
CS961383A2 (en) 1985-07-16
NO834480L (no) 1984-06-21
SU1360585A3 (ru) 1987-12-15
FI834451A0 (fi) 1983-12-05
DK562683D0 (da) 1983-12-06
US4558058A (en) 1985-12-10
DK562683A (da) 1984-06-21
ATE19776T1 (de) 1986-05-15
CA1194480A (en) 1985-10-01
JPS59118783A (ja) 1984-07-09
DE3363545D1 (en) 1986-06-19
KR840006969A (ko) 1984-12-04
PL245200A1 (en) 1985-02-27
GR79484B (da) 1984-10-30
EP0116708B1 (de) 1986-05-14
ZA839382B (en) 1984-08-29
PH20327A (en) 1986-12-02
DE3247118A1 (de) 1984-06-20
AU2253383A (en) 1984-06-28
FI834451A (fi) 1984-06-21
EP0116708A1 (de) 1984-08-29
HU194556B (en) 1988-02-29
ES8406193A1 (es) 1984-08-01
DD215548A5 (de) 1984-11-14
ES528175A0 (es) 1984-08-01

Similar Documents

Publication Publication Date Title
CS241144B2 (en) Method of new substituted 1,4-dihydropyridines production
DK1907382T3 (da) Nitrocatecholderivater som comt-inhibitorer
CN111757875A (zh) 作为心肌节抑制剂的二氢苯并呋喃和茚类似物
BR112014026643B1 (pt) Derivados de imidazotiadiazol e imidazopirazina como inibidores de receptor 4 ativado por protease (par4) para o tratamento de agregação de plaqueta, seus usos e composição farmacêutica
CA2971357A1 (en) Amido thiadiazole derivatives as nadph oxidase inhibitors
EP2597089A1 (en) Tricyclic heterocyclic compounds
US5352684A (en) Pyridines as medicaments
CN112409293B (zh) 苯并噻嗪酮化合物及其制备方法与作为抗结核药物的应用
CA2780905A1 (en) Azocyclic inhibitors of fatty acid amide hydrolase
WO2016017826A1 (ja) キサンチンオキシダーゼ阻害薬
PH26181A (en) Antidepressive substituted N-[{4-piperidinyl)alkyl] bicyclic condensed oxazol and thiazolamines
DE10237883A1 (de) Substituierte Isoxazolderivate und ihre Verwendung in der Pharmazie
US4705786A (en) Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents
ES2911049T3 (es) Antagonistas heterocíclicos de P2X7
US4760147A (en) Optically active, substituted 1,4-dihydropyridines and their use as medicaments
CA2098779A1 (en) Phenyl-1,2,5-oxadiazolecarboxamide-2-oxides
US4681891A (en) Dihydro-2,6-dimethyl pyridines, formulations and method of use for treating angina pectoris, high blood pressure or disturbances of cerebral or peripheral blood flow
JPH0413679A (ja) 新規ジヒドロピリジン誘導体
US20060247233A1 (en) Thiazoles inhibitors of the alk-5 receptor
AU764627B2 (en) Dihydropyrazine derivatives as NPY antagonists
JPH0249792A (ja) スルフェンアミド誘導体
DE3709352A1 (de) 1,4-dihydropyridinmischung
DE4401150A1 (de) Furazancarbonsäurederivate
HU194170B (en) Process for production of derivatives of dihydropiridin with positive inotrop influence and medical compounds containing thereof